Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Volatile Stock Indices require careful risk management and agile tactics. This view helps you adapt strategies to sudden price moves and liquidity shifts.
19,564 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
The quantum computing space just crossed a major milestone with its first traditional IPO. This guide breaks down wha...
Analysts outline a path for Amazon to approach $300 in the next 12-15 months, anchored by cloud, ads, and Prime-drive...
With Ford shares pressed lower by EV doubts and recalls, investors are weighing whether a cheap price reflects a dura...
A stablecoin tied strategy stock briefly fell below its $1 peg as Bitcoin slid, drawing scrutiny of its collateral st...
Alphabet posts stronger-than-expected Q1 2026 results driven by its vertically integrated AI stack, reinforcing its r...
ExxonMobil stock near $150 highlights a broader earnings and cash-flow story that many retail investors overlook. Her...
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Micron insiders are unloading stock at a pace not seen since 2010, even as MU rockets on AI memory demand. This piece...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
An AI-chip IPO like Cerebras can spark excitement and risk in one breath. cerebras opened $350 nearly, blasting past ...
IBM’s dramatic one-day plunge coincided with blockbuster bank profits, fueling a debate over whether markets are misp...